Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns74
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma66
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?64
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype46
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD43
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease37
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease32
HBV Biomarkers and Their Role in Guiding Treatment Decisions30
Genetic and Epigenetic Basis of Drug-Induced Liver Injury29
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy27
Hepatic Alveolar Echinococcosis26
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis23
Physiomimetic In Vitro Human Models for Viral Infection in the Liver22
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems21
Wilson Disease: Novel Diagnostic and Therapeutic Approaches21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies20
Mice Engrafted with Human Liver Cells20
Role of YAP1 Signaling in Biliary Development, Repair, and Disease20
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury19
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective19
Diagnosis and Management of Early Stages of ALD18
Current and Evolving Indications for Simultaneous Liver Kidney Transplantation16
Interleukin-17 in Liver Disease Pathogenesis14
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity13
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination13
Circadian Regulation of Gene Expression and Metabolism in the Liver13
12
Role of Complement in Liver Diseases12
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure11
Erratum to: Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics11
Liver Neurobiology: Regulation of Liver Functions by the Nervous System11
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases11
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure11
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future10
10
Mesenchymal Stem Cell Transplantation in Liver Diseases10
Management of Portal vein Thrombosis in Cirrhosis10
10
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol10
Novel Biomarkers of AKI in Cirrhosis10
Artificial Intelligence in Hepatology: A Narrative Review10
Endoscopic Advances in Hepatology9
Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution8
Hepatocellular Carcinoma Chemoprevention with Generic Agents8
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease8
Hepatitis B Core-Related Antigen: From Virology to Clinical Application8
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy8
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease8
Hepatitis Delta Infection: A Clinical Review8
Erratum to: Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis8
0.034463167190552